Severe migraine headaches are caused by ribavirin but not by interferon α-2B in combination therapy for chronic hepatitis C

Journal of Hepatology

Volumn 38, Issue 6, 2003, Pages 871-872

  Bräu, Norbert ^a,b   Bini, Edmund J ^a,c   Stancic, Saray ^a,b   Finch, Douglas A ^a   Aytaman, Ayse ^a,d  

^a Veterans Integrated Service Network 3   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Veterans Affairs NY Harbor Healthcare System Room 13051 C   (United States)

^d Medical Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA2B INTERFERON; ANALGESIC AGENT; BUTALBITAL; CAFFEINE; RIBAVIRIN;

ADULT; CLINICAL ARTICLE; DOSE RESPONSE; DRUG WITHDRAWAL; HEPATITIS C; HUMAN; LETTER; MALE; MIGRAINE; MONOTHERAPY; PRIORITY JOURNAL;

EID: 18744433297     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00091-6     Document Type: Letter

References (5)

1. Di Bisceglie AM, Conjeevaram HS, Ried MW, Sallie R, Park Y, Yurdaydin C, et al. Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995;123:897-903.
2. Dusheiko G, Main J, Thomas H, Reichard O, Lee C, Dhillon A, et al. Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J Hepatol 1996;25:591-598.
3. Jane EJ, Lo SK, Riordan SM, Portmann BC, Lau JY, Naoumov NV, Williams R. A randomized study comparing ribavirin and interferon alpha monotherapy for hepatitis C recurrence after liver transplantation. Hepatology 1998;27:1403-1407.
4. Schering Corp. Rebetron® package insert (Revision). Kenilworth, NJ: Schering, 2000.
5. IHS. Diagnostic criteria for migraine headaches. The IHS members' handbook, International Headache Society, 1997. pp. 54-63.